Immunotherapy biomarkers 2016: overcoming the barriers

This report summarizes the symposium, ‘Immunotherapy Biomarkers 2016: Overcoming the Barriers’, which was held on April 1, 2016 at the National Institutes of Health in Bethesda, Maryland. The symposium, cosponsored by the Society for Immunotherapy of Cancer (SITC) and the National Cancer Institute (...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulley, James L., Berzofsky, Jay A., Butler, Marcus O., Cesano, Alessandra, Fox, Bernard A., Gnjatic, Sacha, Janetzki, Sylvia, Kalavar, Shyam, Karanikas, Vaios, Khleif, Samir N., Kirsch, Ilan, Lee, Peter P., Maccalli, Cristina, Maecker, Holden, Schlom, Jeffrey, Seliger, Barbara, Siebert, Janet, Stroncek, David F., Thurin, Magdalena, Yuan, Jianda, Butterfield, Lisa H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359902/
https://www.ncbi.nlm.nih.gov/pubmed/28653584
http://dx.doi.org/10.1186/s40425-017-0225-6
Descripción
Sumario:This report summarizes the symposium, ‘Immunotherapy Biomarkers 2016: Overcoming the Barriers’, which was held on April 1, 2016 at the National Institutes of Health in Bethesda, Maryland. The symposium, cosponsored by the Society for Immunotherapy of Cancer (SITC) and the National Cancer Institute (NCI), focused on emerging immunotherapy biomarkers, new technologies, current hurdles to further progress, and recommendations for advancing the field of biomarker development.

Ejemplares similares